Skip to main content
Erschienen in: Surgery Today 12/2016

16.04.2016 | Original Article

Sublobar resection versus lobectomy for stage I non-small cell lung cancer: an appropriate choice in elderly patients?

verfasst von: Alfonso Fiorelli, Francesco Paolo Caronia, Niccolò Daddi, Domenico Loizzi, Luca Ampollini, Nicoletta Ardò, Luigi Ventura, Paolo Carbognani, Rossella Potenza, Francesco Ardissone, Francesco Sollitto, Sandro Mattioli, Francesco Puma, Mario Santini, Mark Ragusa

Erschienen in: Surgery Today | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Purposes

The aim of this study was to evaluate whether sublobar resection could achieve recurrence and survival rates equivalent to lobectomy in high-risk elderly patients.

Methods

We conducted a retrospective multicenter study that including all consecutive patients (aged >75 years) who underwent operation for clinical stage I non-small cell lung cancer (NSCLC). The clinicopathological data, postoperative morbidity and mortality, recurrence rate and vital status were retrieved. The overall survival, cancer-specific survival and disease-free survival were also assessed.

Results

Two hundred and thirty-nine patients (median age 78 years) were enrolled. Lobectomies were performed in 149 (62.3 %) patients and sublobar resections in 90 (39 segmentectomies, 51 wedge resections). There were no differences in the recurrence rates following lobar versus sublobar resections (19 versus 23 %, respectively; p = 0.5) or the overall survival (p = 0.1), cancer-specific survival (p = 0.3) or disease-free survival (p = 0.1). After adjusting for 1:1 propensity score matching and a matched pair analysis, the results remained unchanged. A tumor size >2 cm and pN2 disease were independent negative prognostic factors in unmatched (p = 0.01 and p = 0.0003, respectively) and matched (p = 0.02 and p = 0.005, respectively) analyses.

Conclusions

High-risk elderly patients may benefit from sublobar resection, which provides an equivalent long-term survival compared to lobectomy.
Literatur
1.
Zurück zum Zitat Aberle DR, Abtin F, Brown K. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. J Clin Oncol. 2013;31(8):1002–8.CrossRefPubMedPubMedCentral Aberle DR, Abtin F, Brown K. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. J Clin Oncol. 2013;31(8):1002–8.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Liu Y, Huang C, Liu H, Chen Y, Li S. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study. World J Surg Oncol. 2014;12:138.CrossRefPubMedPubMedCentral Liu Y, Huang C, Liu H, Chen Y, Li S. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study. World J Surg Oncol. 2014;12:138.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Fan J, Wang L, Jiang GN, Gao W. Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies. Ann Surg Oncol. 2012;19:661–8.CrossRefPubMed Fan J, Wang L, Jiang GN, Gao W. Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies. Ann Surg Oncol. 2012;19:661–8.CrossRefPubMed
4.
Zurück zum Zitat Zhang Y, Sun Y, Wang R, Ye T, Zhang Y, Chen H. Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer. J Surg Oncol. 2015;111:334–40.CrossRefPubMed Zhang Y, Sun Y, Wang R, Ye T, Zhang Y, Chen H. Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer. J Surg Oncol. 2015;111:334–40.CrossRefPubMed
5.
Zurück zum Zitat Cao C, Chandrakumar D, Gupta S, Yan TD, Tian DH. Could less be more?—a systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection. Lung Cancer. 2015. Cao C, Chandrakumar D, Gupta S, Yan TD, Tian DH. Could less be more?—a systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection. Lung Cancer. 2015.
6.
Zurück zum Zitat Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615–22.CrossRefPubMed Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615–22.CrossRefPubMed
7.
Zurück zum Zitat Whitson BA, Groth SS, Andrade RS, Maddaus MA, Habermann EB, D’Cunha J. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis. Ann Thorac Surg. 2011;92:1943–50.CrossRefPubMed Whitson BA, Groth SS, Andrade RS, Maddaus MA, Habermann EB, D’Cunha J. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis. Ann Thorac Surg. 2011;92:1943–50.CrossRefPubMed
8.
Zurück zum Zitat Wang S, Wong ML, Hamilton N, Davoren JB, Jahan TM, Walter LC. Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol. 2012;30:1447–55.CrossRefPubMedPubMedCentral Wang S, Wong ML, Hamilton N, Davoren JB, Jahan TM, Walter LC. Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol. 2012;30:1447–55.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Fiorelli A, Vicidomini G, Mazzella A, Messina G, Milione R, Di Crescenzo VG, et al. The influence of body mass index and weight loss on outcome of elderly patients undergoing lung cancer resection. Thorac Cardiovasc Surg. 2014;62:578–87.CrossRefPubMed Fiorelli A, Vicidomini G, Mazzella A, Messina G, Milione R, Di Crescenzo VG, et al. The influence of body mass index and weight loss on outcome of elderly patients undergoing lung cancer resection. Thorac Cardiovasc Surg. 2014;62:578–87.CrossRefPubMed
10.
Zurück zum Zitat Okami J, Ito Y, Higashiyama M, Nakayama T, Tokunaga T, Maeda J, et al. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer. Ann Thorac Surg. 2010;90:1651–6.CrossRefPubMed Okami J, Ito Y, Higashiyama M, Nakayama T, Tokunaga T, Maeda J, et al. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer. Ann Thorac Surg. 2010;90:1651–6.CrossRefPubMed
11.
Zurück zum Zitat Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest. 2005;128:237–45.CrossRefPubMed Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest. 2005;128:237–45.CrossRefPubMed
12.
Zurück zum Zitat Dell’Amore A, Monteverde M, Martucci N, Sanna S, Caroli G, Dolci G, et al. Lobar and sub-lobar lung resection in octogenarians with early stage non-small cell lung cancer: factors affecting surgical outcomes and long-term results. Gen Thorac Cardiovasc Surg. 2015;63:222–30.CrossRefPubMed Dell’Amore A, Monteverde M, Martucci N, Sanna S, Caroli G, Dolci G, et al. Lobar and sub-lobar lung resection in octogenarians with early stage non-small cell lung cancer: factors affecting surgical outcomes and long-term results. Gen Thorac Cardiovasc Surg. 2015;63:222–30.CrossRefPubMed
13.
Zurück zum Zitat Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, for the Japanese Joint Committee of Lung Cancer Registry, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer. J Thorac Oncol. 2009;4:1247–53.CrossRefPubMed Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, for the Japanese Joint Committee of Lung Cancer Registry, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer. J Thorac Oncol. 2009;4:1247–53.CrossRefPubMed
14.
Zurück zum Zitat Landreneau RJ, Normolle DP, Christie NA, Awais O, Wizorek JJ, Abbas G, et al. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. J Clin Oncol. 2014;32:2449–55.CrossRefPubMedPubMedCentral Landreneau RJ, Normolle DP, Christie NA, Awais O, Wizorek JJ, Abbas G, et al. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. J Clin Oncol. 2014;32:2449–55.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Sienel W, Dango S, Kirschbaum A, Cucuruz B, Hörth W, Stremmel C, et al. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections. Eur J Cardiothorac Surg. 2008;33:728–34.CrossRefPubMed Sienel W, Dango S, Kirschbaum A, Cucuruz B, Hörth W, Stremmel C, et al. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections. Eur J Cardiothorac Surg. 2008;33:728–34.CrossRefPubMed
16.
Zurück zum Zitat Wolf AS, Richards WG, Jaklitsch MT, Gill R, Chirieac LR, Colson YL, et al. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg. 2011;92:1819–23.CrossRefPubMed Wolf AS, Richards WG, Jaklitsch MT, Gill R, Chirieac LR, Colson YL, et al. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg. 2011;92:1819–23.CrossRefPubMed
17.
Zurück zum Zitat El-Sherif A, Gooding WE, Santos R, Pettiford B, Ferson PF, Fernando HC, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg. 2006;82:408–15.CrossRefPubMed El-Sherif A, Gooding WE, Santos R, Pettiford B, Ferson PF, Fernando HC, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg. 2006;82:408–15.CrossRefPubMed
18.
Zurück zum Zitat Altorki NK, Yip R, Hanaoka T, Bauer T, Aye R, Kohman L, I-ELCAP Investigators, et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg. 2014;147:754–62.CrossRefPubMed Altorki NK, Yip R, Hanaoka T, Bauer T, Aye R, Kohman L, I-ELCAP Investigators, et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg. 2014;147:754–62.CrossRefPubMed
19.
Zurück zum Zitat Kent M, Landreneau R, Mandrekar S, Hillman S, Nichols F, Jones D, et al. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients. Ann Thorac Surg. 2013;96:1747–54.CrossRefPubMed Kent M, Landreneau R, Mandrekar S, Hillman S, Nichols F, Jones D, et al. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients. Ann Thorac Surg. 2013;96:1747–54.CrossRefPubMed
20.
Zurück zum Zitat Fang W, Xiang Y, Zhong C, Chen Q. The IASLC/ATS/ERS classification of lung adenocarcinoma—a surgical point of view. J Thorac Dis. 2014;6:S552–60.PubMedPubMedCentral Fang W, Xiang Y, Zhong C, Chen Q. The IASLC/ATS/ERS classification of lung adenocarcinoma—a surgical point of view. J Thorac Dis. 2014;6:S552–60.PubMedPubMedCentral
21.
Zurück zum Zitat Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132(4):769–75.CrossRefPubMed Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132(4):769–75.CrossRefPubMed
22.
Zurück zum Zitat Nakamura H, Takagi M. Clinical impact of the new IASLC/ATS/ERS lung adenocarcinoma classification for chest surgeons. Surg Today. 2015;45(11):1341–51.CrossRefPubMed Nakamura H, Takagi M. Clinical impact of the new IASLC/ATS/ERS lung adenocarcinoma classification for chest surgeons. Surg Today. 2015;45(11):1341–51.CrossRefPubMed
23.
Zurück zum Zitat Takenaka T, Inamasu E, Yoshida T, Toyokawa G, Nosaki K, Hirai F, Yamaguchi M, Seto T, Takenoyama M, Ichinose Y. Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer. Surg Today. 2015. PubMed PMID: 26070907 (epub ahead of print). Takenaka T, Inamasu E, Yoshida T, Toyokawa G, Nosaki K, Hirai F, Yamaguchi M, Seto T, Takenoyama M, Ichinose Y. Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer. Surg Today. 2015. PubMed PMID: 26070907 (epub ahead of print).
24.
Zurück zum Zitat Nakayama H, Yamada K, Saito H, Oshita F, Ito H, Kameda Y, Noda K. Sublobar resection for patients with peripheral small adenocarcinomas of the lung: surgical outcome is associated with features on computed tomographic imaging. Ann Thorac Surg. 2007;84(5):1675–9.CrossRefPubMed Nakayama H, Yamada K, Saito H, Oshita F, Ito H, Kameda Y, Noda K. Sublobar resection for patients with peripheral small adenocarcinomas of the lung: surgical outcome is associated with features on computed tomographic imaging. Ann Thorac Surg. 2007;84(5):1675–9.CrossRefPubMed
25.
Zurück zum Zitat Dominguez-Ventura A, Allen MS, Cassivi SD, Nichols FC, Deshamps C, Pairolero PC. Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg. 2006;82:1175–9.CrossRefPubMed Dominguez-Ventura A, Allen MS, Cassivi SD, Nichols FC, Deshamps C, Pairolero PC. Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg. 2006;82:1175–9.CrossRefPubMed
26.
Zurück zum Zitat Port JL, Kent MS, Korst RJ, Libby D, Pasmantier M, Altorki NK. Tumor size predicts survival within stage IA non-small cell lung cancer. Chest. 2003;124(5):1828–33.CrossRefPubMed Port JL, Kent MS, Korst RJ, Libby D, Pasmantier M, Altorki NK. Tumor size predicts survival within stage IA non-small cell lung cancer. Chest. 2003;124(5):1828–33.CrossRefPubMed
27.
Zurück zum Zitat Okada M, Sakamoto T, Nishio W, Uchino K, Tsubota N. Characteristics and prognosis of patients after resection of non-small cell lung carcinoma measuring 2 cm or less in greatest dimension. Cancer. 2003;98:535–41.CrossRefPubMed Okada M, Sakamoto T, Nishio W, Uchino K, Tsubota N. Characteristics and prognosis of patients after resection of non-small cell lung carcinoma measuring 2 cm or less in greatest dimension. Cancer. 2003;98:535–41.CrossRefPubMed
Metadaten
Titel
Sublobar resection versus lobectomy for stage I non-small cell lung cancer: an appropriate choice in elderly patients?
verfasst von
Alfonso Fiorelli
Francesco Paolo Caronia
Niccolò Daddi
Domenico Loizzi
Luca Ampollini
Nicoletta Ardò
Luigi Ventura
Paolo Carbognani
Rossella Potenza
Francesco Ardissone
Francesco Sollitto
Sandro Mattioli
Francesco Puma
Mario Santini
Mark Ragusa
Publikationsdatum
16.04.2016
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 12/2016
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-016-1314-8

Weitere Artikel der Ausgabe 12/2016

Surgery Today 12/2016 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.